Astri Fjelde Maaland

3PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 29, 2022
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.

Marion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares

|Mar 19, 2020
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003.

Astri Fjelde Maaland, Amal Saidi, Julien Torgue

|Jul 17, 2019
Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003.

Astri Fjelde Maaland, Helen Heyerdahl, Adam O'Shea

Pageof 1

Frequent Collaborators

1 joint publications

Ada Repetto-Llamazares

1 joint publications

Anne Hansen Ree